---
schema_version: "secwatch.filing_event.v1"
accession: "0001299130-26-000117"
form_type: "8-K"
ticker: "PACB"
cik: "0001299130"
company_name: "PACIFIC BIOSCIENCES OF CALIFORNIA, INC."
filed_at: "2026-08-05T20:23:30+00:00"
generated_at: "2026-08-05T20:24:16.673428+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# PacBio Q2 revenue $39M, net loss $44.7M; CEO Henry steps down, Van Oene appointed; restructuring cuts 8% workforce

## Summary
- Q2 revenue $39.0M (down 2% YoY); GAAP net loss $44.7M ($0.14 loss per share); non-GAAP net loss $41.9M.
- Revio placements 20, Vega placements 26; consumable revenue $20.1M; annualized Revio pull-through ~$202K.
- Full-year 2026 revenue guidance $155-165M; commenced SPRQ-Nx chemistry rollout at $345/genome.
- CEO Christian Henry steps down effective Aug 5; COO Mark Van Oene appointed President and CEO; Henry stays as advisor through Dec 2026.
- Restructuring plan cuts ~40 employees (8% workforce); expects $30-40M annualized OpEx reduction by end 2027; $2M pre-tax charges in Q3.

## SEC filing metadata
- accession: 0001299130-26-000117
- form_type: 8-K
- ticker: PACB
- cik: 0001299130
- company_name: PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
- filed_at: 2026-08-05T20:23:30+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 2.05, 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1299130/000129913026000117/0001299130-26-000117-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1299130/000129913026000117/pacb-20260730.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001299130-26-000117
- JSON: https://secwatch.observer/filing/0001299130-26-000117.json
- Plain text: https://secwatch.observer/filing/0001299130-26-000117.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.